Drugs for Cocaine Dependence (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 231)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Caffeine |
Approved |
Phase 4 |
|
58-08-2 |
2519 |
Synonyms:
1,3,7-TRIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-TRIMETHYLPURINE-2,6-QUINONE
1,3,7-Trimethylxanthine
137X
1-Methyltheobromine
1-Methyl-theobromine
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
7-Methyl theophylline
7-Methyltheophylline
Alert-Pep
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anoquan
Berlin-chemie brand OF caffeine
Bristol-myers squibb brand OF caffeine
Cafamil
CAFCIT
Cafecon
Cafeina
Cafeína
Cafeine
Caféine
Cafergot
Caffedrine
Caffedrine Caplets
Caffein
Caffeine
CAFFEINE MELTING POINT STANDARD
Caffeine Pure
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, Synthetic
Caffeinum
Caffine
Cafipel
CFF
Coffein
COFFEINE
Coffeinum
Coffeinum N
Coffeinum purrum
Compound 65
Darvon Compound
Darvon Compound-65
Dasin
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
Diurex
Durvitan
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
FEMA NO. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline brand OF caffeine
Guaranine
Hycomine
Invagesic
|
Invagesic Forte
Keep Alert
Kofein
Koffein
Lanorinal
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
Merck dura brand OF caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Migergot
Miudol
Monohydrate caffeine
Monomethyl Derivative of Theophylline
Natural Caffeinum
Nix Nap
No doz
Nodaca
No-Doz
NODOZ
NODOZ CAPLETS AND CHEWABLE TABLETS
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
NSC-5036
Organex
Orphengesic
Orphengesic Forte
Passauer brand OF caffeine
Pep-Back
Percoffedrinol N
Percutaféine
Peyona®
Phensal
Pierre fabre brand OF caffeine
PRO-PLUS
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick pep
Quick-pep
QuickPep
Refresh'n
Republic drug brand OF caffeine
Respia
Seid brand OF caffeine
SK 65 Compound
Stim
Synalgos-Dc
Teina
Teína
Thein
Theine
Theobromine ME
Theophylline ME
Thompson brand 1 OF caffeine
Thompson brand 2 OF caffeine
Triad
Ultra Pep-Back
Vivarin
Wake-Up
Wigraine
YEAST-VITE
ZANTHINE
|
|
2 |
|
Lamotrigine |
Approved, Investigational |
Phase 4 |
|
84057-84-1 |
3878 |
Synonyms:
3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine
BW 430C
BW-430C
Crisomet
GIZORD
GW 273293
Labileno
Lamictal
LAMICTAL CD
LAMICTAL ODT
|
LAMICTAL XR
Lamictal®
Lamictin
Lamiktal
Lamotrigina
Lamotrigina [Spanish]
Lamotrigine
Lamotriginum
Lamotriginum [Latin]
QIN
QÍN
|
|
3 |
|
Lecithin |
Approved, Experimental, Investigational, Nutraceutical |
Phase 4 |
|
8002-43-5, 1446756-47-3, 18656-38-7 |
26197 9547096 6323481 |
Synonyms:
(1)-(7-Myristoyl-4-oxido-10-oxo-3,5,9-trioxa-4-phosphatricosyl)trimethylammonium 4-oxide
(2S)-2-Amino-3-({[(2R)-2-(butanoyloxy)-3-(propanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoate
[2-({[2,3-bis(tetradecanoyloxy)propyl] phosphonato}oxy)ethyl]trimethylazanium
1,2 Dimyristoyl glycero 3 phosphorylcholine
1,2 Ditetradecanoyl glycero 3 phosphocholine
1,2 Ditetradecyl glycero 3 phosphocholine
1,2-Dimyristoyl-glycero-3-phosphorylcholine
1,2-Dimyristoyl-sn-glycero-3-phosphatidylcholine
1,2-Dioctadecanoyl-rac-glycero-3-phosphoserine
1,2-Dioctadecanoyl-sn-glycero-3-phosphoserine
1,2-Distearoyl-rac-glycero-3-phosphoserine
1,2-Ditetradecanoyl-glycero-3-phosphocholine
1,2-Ditetradecanoyl-sn-glycero-3-phosphocholine
1,2-Ditetradecyl-glycero-3-phosphocholine
2 Acetamido 2 deoxy D glucose
2 Acetamido 2 deoxyglucose
2,3-Bis(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate
2,3-Bis(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphoric acid
2-Acetamido-2-deoxy-D-glucose
2-Acetamido-2-deoxyglucose
3-O-sn-Phosphatidyl-L-serine
Acetylglucosamine
D-GlcNAc
dimyristoyl phosphatidylcholine
Dimyristoyllecithin
|
Dimyristoylphosphatidylcholine
Dimyristoyl-phosphatidylcholine
Distearoyl phosphatidylserine
distearoylphosphatidylserine|PS
DMCP
DMPC
Lecithins
l-α-dimyristoylphosphatidylcholine
N Acetyl D glucosamine
N-Acetylchitosamine
N-Acetyl-D-glucosamine
O3-Phosphatidyl-L-serine
Phosphatidyl serine
Phosphatidylcholine
Phosphatidyl-L-serine
Phosphatidylserine
Phosphatidylserine(18:0/18:0)
Phosphatidylserine(36:0)
Phospholutein
PS
PS(18:0/18:0)
PS(36:0)
pSer(18:0/18:0)
pSer(36:0)
|
|
4 |
|
Choline |
Approved, Nutraceutical |
Phase 4 |
|
62-49-7 |
305 |
Synonyms:
(2-Hydroxyethyl)trimethyl ammonium
(2-Hydroxyethyl)trimethylammonium
(2-HYDROXYETHYL)TRIMETHYLAZANIUM
(beta-Hydroxyethyl)trimethylammonium
2-HYDROXYETHYL-TRIMETHYL-AMMONIUM
2-HYDROXYETHYL-TRIMETHYL-AZANIUM
2-Hydroxy-N,N,N-trimethylethanaminium
2-Hydroxy-N,N,N-trimethyl-ethanaminium
Bilineurine
Biocolina
Biocoline
Bitartrate, choline
Bursine
Chloride, choline
CHOLINE
Choline bitartrate
Choline cation
Choline chloride
Choline citrate
Choline hydroxide
|
CHOLINE ion
Choline O sulfate
Choline O-sulfate
Cholinum
Citrate, choline
Fagine
Hepacholine
Hormocline
Hydroxide, choline
Lipotril
N,N,N-Trimethylethanolammonium
N,N,N-Trimethylethanol-ammonium
Neocolina
N-Trimethylethanolamine
O-Sulfate, choline
Paresan
Trimethylethanolamine
Vidine
Vitamin J
|
|
5 |
|
Phosphodiesterase Inhibitors |
|
Phase 4 |
|
|
|
6 |
|
Antidepressive Agents |
|
Phase 4 |
|
|
|
7 |
|
Sodium Channel Blockers |
|
Phase 4 |
|
|
|
8 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
9 |
|
Quetiapine Fumarate |
|
Phase 4 |
|
111974-72-2 |
|
Synonyms:
ICI-204636
QUETIAPINE FUMARATE
SEROQUEL
|
SEROQUEL XR
ZD-5077
ZM-204636
|
|
10 |
|
Calcium, Dietary |
|
Phase 4 |
|
|
|
11 |
|
calcium channel blockers |
|
Phase 4 |
|
|
|
12 |
|
Antimetabolites |
|
Phase 4 |
|
|
|
13 |
|
Hypolipidemic Agents |
|
Phase 4 |
|
|
|
14 |
|
Lipid Regulating Agents |
|
Phase 4 |
|
|
|
15 |
|
Cytidine Diphosphate Choline |
|
Phase 4 |
|
|
|
16 |
|
Calcium |
Nutraceutical |
Phase 4 |
|
7440-70-2 |
271 |
Synonyms:
Ca
Ca(2+)
Ca2+
Calcio
CALCIUM
Calcium element
|
CALCIUM ion
Calcium(2+)
Calcium, doubly charged positive ion
Calcium, elemental
Elemental calcium
Kalzium
|
|
17 |
|
Oxytocin |
Approved, Vet_approved |
Phase 2, Phase 3 |
|
50-56-6 |
439302 53477758 |
Synonyms:
(2S)-2-[({1-[(4R,7S,10S,13S,16S,19R)-19-amino-13-[(2S)-butan-2-yl]-6,9,12,15,18-pentahydroxy-10-[2-(C-hydroxycarbonimidoyl)ethyl]-7-[(C-hydroxycarbonimidoyl)methyl]-16-[(4-hydroxyphenyl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carbonyl]pyrrolidin-2-yl}(hydroxy)methylidene)amino]-N-[(C-hydroxycarbonimidoyl)methyl]-4-methylpentanimidate
(Arg8)-vasopressin
(Arg8)-vasotocin
[<sup>3</sup>H]oxytocin
alpha-Hypophamine
Argipressin
Argpressin acetate
Biotinyl-(arg8)-vasopressin
Cys-tyr-ile-GLN-asn-cys-pro-arg-gly-NH2
Cys-tyr-ile-GLN-asn-cys-pro-leu-gly-NH2
Cys-tyr-ile-THR-asn-cys-gly-leu-gly-NH2
Cys-tyr-phe-GLN-asn-cys-pro-arg-gly-NH2
Cys-tyr-phe-GLN-asn-cys-pro-lys-gly-NH2
Disulfide bridge cys1-cys6
Gly-leu-pro-c
Ocytocin
|
ORASTHIN
Oxitocina
OXT
OXYTOCIN
Oxytocin 10 usp units in dextrose 5%
Oxytocin 20 usp units in dextrose 5%
Oxytocin 5 usp units in dextrose 5%
Oxytocin acetate
Oxytocin injection
PITOCIN
SID29217903
SID50111741
SYNTOCINON
SYNTOMETRINE
SYT670
TTA-121
|
|
18 |
|
Bupropion |
Approved |
Phase 2, Phase 3 |
|
31677-93-7, 34841-39-9, 34911-55-2 |
444 |
Synonyms:
(+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
(+-)-Bupropion
Amfebutamona
Amfebutamone
AMFEBUTAMONE HCL
amfebutamone|BW-323|Wellbutrin®|Zyban®
Amfebutamonum
BUPROPION
BUPROPION HCL
Bupropion hydrochloride
Bupropion hydrochloride, (+-)-isomer
Bupropion, (+-)-isomer
BW-323
Esteve brand OF bupropion hydrochloride
FORFIVO XL
glaxo Wellcome brand 1 OF bupropion hydrochloride
|
glaxo Wellcome brand 2 OF bupropion hydrochloride
glaxo Wellcome brand 3 OF bupropion hydrochloride
GlaxoSmithKline brand 1 OF bupropion hydrochloride
GlaxoSmithKline brand 2 OF bupropion hydrochloride
NSC-315851
Quomen
Wellbatrin
Wellbutrin
WELLBUTRIN 100
WELLBUTRIN 75
WELLBUTRIN SR
WELLBUTRIN XL
Zyban
Zyban (anti-smoking)
Zyban (bupropion)
Zyntabac
|
|
19 |
|
Citalopram |
Approved |
Phase 2, Phase 3 |
|
59729-32-7, 59729-33-8 |
2771 |
Synonyms:
[<sup>3</sup>H]-citalopram
Akarin
Bonitrile
Celapram
Celexa
Celexa®|Cipramil®|LU-10171B
Celius
Ciazil
Cilift
Cipram
CIPRAMIL
Ciprapine
Citabax
Citadur
Citalec
Citalopram
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
Citol
Citopam
Citox
|
Citrol
Cytalopram
Dalsan
Elopram
Escitalopram
Escitalopram oxalate
Humorup
Lexapro
LU 10-171-B
LU-10-171-B
Nitalapram
Oropram
PAXORAN
Pramcit
Recital
Seropram
Talam
Talohexal
Temperax
Vodelax
Zentius
Zetalo
|
|
20 |
|
Biperiden |
Approved, Investigational |
Phase 3 |
|
514-65-8 |
2381 |
Synonyms:
1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol
a-5-Norbornen-2-yl-a-phenyl-1-piperidinepropanol
a-Bicyclo[2.2.1]hept-5-en-2-yl-a-phenyl-1-piperidinepropanol
Akineton
Akineton®|biperiden HCl|biperiden lactate
alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol
alpha-Bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol
alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol
Beperiden
Biperiden
Biperiden hydrochloride
|
Biperiden, 1R-(1 alpha,2 alpha(r*),4 alpha)-isomer
Biperiden, 1S-(1 alpha,2 alpha(r*),4 alpha)-isomer
Biperidene
Biperideno
Biperidenum
Biperidine
Hydrochloride, biperiden
KL 373
Α-5-norbornen-2-yl-α-phenyl-1-piperidinepropanol
Α-bicyclo[2.2.1]hept-5-en-2-yl-α-phenyl-1-piperidinepropanol
|
|
21 |
|
Topiramate |
Approved |
Phase 2, Phase 3 |
|
97240-79-4 |
5284627 |
Synonyms:
[(1R,2S,6S,9R)-4,4,11,11-TETRAMETHYL-3,5,7,10,12-PENTAOXATRICYCLO[7.3.0.0^{2,6}]DODECAN-6-YL]METHYL SULFAMATE
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamic acid
2,3-4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
|
Epitomax
epitomax|Eprontia® (liquid formulation)|MCN-4853|RWJ-17021|Topamax®
MCN-4853
QUDEXY XR
RWJ-17021
RWJ-17021-000
Tipiramate
Tipiramate [French]
Tipiramato
Tipiramato [Spanish]
Tipiramic acid
Topamax
Topamax sprinkle
TOPIRAMATE
topiramate tablet
Topiramato
Topiramato [INN-Spanish]
Topiramatum
Topiramatum [INN-Latin]
Topiramic acid
Topomax
TPM
Trokendi XR
USL255
USL-255
|
|
22 |
|
Mirtazapine |
Approved |
Phase 2, Phase 3 |
|
85650-52-8, 61337-67-5 |
4205 |
Synonyms:
(N-Methyl-11C)mirtazapine
(S)-Mirtazapine
1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine
2-METHYL-1,2,3,4,10,14B-HEXAHYDROPYRAZINO[2,1-A]PYRIDO[2,3-C][2]BENZAZEPINE
6 Azamianserin
6-Azamianserin
Avanza
Axit
Celltech brand OF mirtazapine
Esmirtazapine
Mepirzapine
Mepirzepine
Mirtabene
Mirtaz
Mirtazapin
Mirtazapina
Mirtazapina [INN-Spanish]
Mirtazapine
|
Mirtazapine [Usan:Ban:Inn]
Mirtazapinum
Mirtazapinum [INN-Latin]
Mirtazepine
Mirtazon
Mundogen brand OF mirtazapine
Norset
ORG-3770
ORG-3770|Remeron®
Organon brand OF mirtazapine
Promyrtil
Reflex
Remergil
Remergon
Remeron
REMERON SOLTAB
Rexer
Zispin
|
|
23 |
|
Carbidopa |
Approved |
Phase 2, Phase 3 |
|
28860-95-9 |
34359 38101 |
Synonyms:
(-)-L-a-Hydrazino-3,4-dihydroxy-a-methylhydrocinnamate
(-)-L-a-Hydrazino-3,4-dihydroxy-a-methylhydrocinnamic acid
(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamate
(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid
(-)-L-ALPHA-HYDRAZINO-3,4-DIHYDROXY-ALPHA-METHYLHYDROCINNAMIC ACID MONOHYDRATE
(-)-L-Α-hydrazino-3,4-dihydroxy-α-methylhydrocinnamate
(-)-L-Α-hydrazino-3,4-dihydroxy-α-methylhydrocinnamic acid
(2S)-3-(3,4-DIHYDROXYPHENYL)-2-HYDRAZINYL-2-METHYLPROPANOIC ACID HYDRATE
(2S)-3-(3,4-DIHYDROXYPHENYL)-2-HYDRAZINYL-2-METHYLPROPANOIC ACID MONOHYDRATE
(AlphaS)-a-hydrazino-3,4-dihydroxy-a-methylbenzenepropanoate
(AlphaS)-a-hydrazino-3,4-dihydroxy-a-methylbenzenepropanoic acid
(AlphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoate
(AlphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid
(ALPHAS)-ALPHA-HYDRAZINO-3,4-DIHYDROXY-ALPHA-METHYLBENZENEPROPANOIC ACID MONOHYDRATE
(AlphaS)-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoate
(AlphaS)-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid
(S)-(−)-carbidopa
(S)-(-)-Carbidopa
(S)-(-)-CARBIDOPA HYDRATE
(S)-(−)-CARBIDOPA HYDRATE
(S)-Carbidopa
(S)-CARBIDOPA HYDRATE
|
(αS)-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid
Carbidopa
Carbidopa (anhydrous)
CARBIDOPA ANHYDROUS
CARBIDOPA HYDRATE
CARBIDOPA MONOHYDRATE
Carbidopa, (R)-isomer
Carbidopa, (S)-isomer
Carbidopum
CARBIDOPUM MONOHYDRICUM
CDP536
Duodopa®|Lodosyn®|MK 486
L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionate
L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid
L-ALPHA-(3,4-DIHYDROXYBENZYL)-ALPHA-HYDRAZINOPROPIONIC ACID MONOHYDRATE
L-alpha-Methyldopahydrazine
L-a-Methyldopahydrazine
Lodosin
Lodosyn
L-Α-methyldopahydrazine
Methyldopahydrazine
MK-486
|
|
24 |
|
Naltrexone |
Approved, Investigational, Vet_approved |
Phase 2, Phase 3 |
|
16590-41-3 |
5360515 |
Synonyms:
(-)NALTREXONE
(-)naltrexone|naltrexone HCl|ReVia®
17-(Cyclopropylmethyl)-4,5a-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one
Antaxone
Bristol myers squibb brand OF naltrexone hydrochloride
Bristol-myers squibb brand OF naltrexone hydrochloride
Celupan
Du pont brand OF naltrexone hydrochloride
EN-1639A
EN-1639A [AS HYDROCHLORIDE]
EN-1639A FREE BASE
Hydrochloride, naltrexone
Lacer brand OF naltrexone hydrochloride
Lamepro brand OF naltrexone hydrochloride
MorViva
Nalorex
Naltrexon
Naltrexona
|
Naltrexona [INN-Spanish]
Naltrexone
Naltrexone [Usan:Ban:Inn]
NALTREXONE HCL
Naltrexone hydrochloride
Naltrexonum
Naltrexonum [INN-Latin]
N-Cyclopropylmethyl-14-hydroxydihydromorphinone
N-Cyclopropylmethylnoroxymorphone
Nemexin
Orphan brand OF naltrexone hydrochloride
Pharmazam brand OF naltrexone hydrochloride
PTI-555
ReVia
Schering plough brand OF naltrexone hydrochloride
Schering-plough brand OF naltrexone hydrochloride
TREXAL
Trexan
United drug brand OF naltrexone hydrochloride
Vivitrex
Vivitrol
|
|
25 |
|
Pergolide |
Approved, Investigational, Vet_approved, Withdrawn |
Phase 3 |
|
66104-22-1 |
47811 |
Synonyms:
Athena brand OF pergolide mesylate
Celance
Draxis brand OF pergolide mesylate
Elanco brand OF pergolide mesylate
Lilly brand OF pergolide
Lilly brand OF pergolide mesylate
LY-127809
LY-127809|Permax®
Mesylate, pergolide
|
Parkotil
Pergolida
PERGOLIDE
Pergolide mesylate
Pergolide methanesulfonate
Pergolidum
Permax
Pharken
|
|
26 |
|
Selegiline |
Approved, Investigational, Vet_approved |
Phase 3 |
|
14611-51-9, 14611-52-0 |
5195 26757 |
Synonyms:
(−)-selegiline
Apo-Selegiline
Bristol myers squibb brand OF selegiline
Bristol-myers squibb brand OF selegiline
Carbex
CENTRAPRYL 10
CENTRAPRYL 5
Deprenalin
Deprenil
Deprenyl
Eldepryl
Eldepryl®|L-deprenalin|Otrasel®|Selegene®|Zelapar®
Emsam
ENSAM
Gen-Selegiline
Humex
Hydrochloride, selegiline
Jumex
L-Deprenalin
L-Deprenyl
Novo-Selegiline
Nu-Selegiline
Sd Deprenyl
|
Selegeline Hcl
Selegilina
Selegilina [INN-Spanish]
SELEGILINE
SELEGILINE HCL
Selegiline hydrochloride
Selegiline hydrochloride, (R)-isomer
Selegiline hydrochloride, (R,S)-isomer
Selegiline hydrochloride, (S)-isomer
Selegiline valeant brand
Selegiline, (R)-isomer
Selegiline, (R,S)-isomer
Selegiline, (S)-isomer
Selegilinum
Selegilinum [INN-Latin]
Selegyline
STILLINE 10
STILLINE 5
Valeant brand OF selegiline
VIVAPRYL
Yumex
Zelapar
|
|
27 |
|
Entacapone |
Approved, Investigational |
Phase 2, Phase 3 |
|
130929-57-6 |
5281081 |
Synonyms:
(e)-a-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide
(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide
(e)-Α-cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide
2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide
COM998
Comtan
Comtan®|Comtess®|OR-611
Comtess
Entacapona
|
Entacapona [INN-Spanish]
ENTACAPONE
Entacapone [Usan:Inn]
Entacaponum
Entacaponum [INN-Latin]
N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide
Novartis brand OF entacapone
OR-611
Orion brand OF entacapone
|
|
28 |
|
Nicotine |
Approved |
Phase 3 |
|
54-11-5 |
942 89594 |
Synonyms:
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine
(-)-3-(N-Methylpyrrolidino)pyridine
(−)-nicotine
(-)-Nicotine
(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(+)-Nicotine
(+-)-Nicotine
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(R,S)-Nicotine
(RS)-Nicotine
(S)-(−)-nicotine
(S)-(-)-Nicotine
(S)-3-(1-Methylpyrrolidin-2-yl)pyridine
(S)-3-(N-Methylpyrrolidin-2-yl)pyridine
(S)-Nicotine
1-Methyl-2-(3-pyridal)-pyrrolidene
1-Methyl-2-(3-pyridal)-pyrrolidine
1-Methyl-2-(3-pyridiyl)pyrrolidine
1-Methyl-2-(3-pyridyl)pyrrolidine
2'-beta-H-Nicotine
3-(1-Methyl-2-pyrollidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)-pyridine
3-(1-Methylpyrrolidin-2-yl)pyridine
3-(2-(N-Methylpyrrolidinyl))pyridine
3-(N-Methylpyrollidino)pyridine
3-(N-Methylpyrrolidino)pyridine
3-N-Methylpyrrolidine
a -N-Methylpyrrolidine
alpha-N-Methylpyrrolidine
a-N-Methylpyrrolidine
beta-Pyridyl-alpha-N-methylpyrrolidine
Bitartrate, nicotine
Black Leaf
Black Leaf 40
Campbell's Nico-Soap
Commit
delta-Nicotine
Destruxol
Destruxol Orchid Spray
DL-Tetrahydronicotyrine
D-Nicotine
Emo-Nik
Flux Maag
Fumeto bac
Fumetobac
Habitrol
L(−)-nicotine
L(-)-Nicotine
L-3-(1-Methyl-2-pyrrolidyl)pyridine
L-Nicotine
|
Mach-Nic
Methyl-2-pyrrolidinyl)pyridine
Niagara P.A. Dust
NICABATE
Nicocide
Nicoderm
NICODERM CQ
Nico-Dust
Nico-Fume
NICOPASS
NICOPATCH
Nicorette
NICORETTE INVISI
Nicorette Plus
Nicorette®|Nicotrol®
Nicotin
Nicotina
Nicotine
Nicotine alkaloid
Nicotine betadex
Nicotine bitartrate
Nicotine polacrilex
Nicotine tartrate
NICOTINELL CLASSIC
NICOTINELL SUPPORT
NICOTINELL TTS 10
NICOTINELL TTS 20
NICOTINELL TTS 30
NICOTROL
NICOTROL INHALER
NICOTROL NS
Nic-Sal
Nikotin
Nikotyna
NIQUITIN
NIQUITIN CLR
NIQUITIN MINIS CHERRY
NIQUITIN MINIS MINT
NIQUITIN MINIS ORANGE
NIQUITIN MINT
NIQUITIN PRE-QUIT
NIQUITIN STRIPS MINT
Ortho N-4 Dust
Ortho N-5 Dust
PROSTEP
R)-(+)-Nicotine
STOPPERS
STUBIT
Tartrate, nicotine
Tendust
|
|
29 |
|
Buprenorphine |
Approved, Illicit, Investigational, Vet_approved |
Phase 2, Phase 3 |
|
52485-79-7, 53152-21-9 |
644073 40400 |
Synonyms:
(−)-buprenorphine
(-)-Buprenorphine
17-Cyclopropylmethyl-4,5a-epoxy-7a-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-Cyclopropylmethyl-4,5α-epoxy-7α-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
2-(N-Cyclopropylmethyl-4,5a-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6a-yl)-3,3-dimethyl-2-butanol
2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol
2-(N-Cyclopropylmethyl-4,5α-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6α-yl)-3,3-dimethyl-2-butanol
2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol
21-Cyclopropyl-7a-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-Cyclopropyl-7α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
ALKS-5461 COMPONENT BUPRENORPHINE
BUPEAZE
BUPLAST
Buprel
Buprenex
Buprenex®|Buvidal®|CAM2038|Sixmo® (buprenorphine hydrochloride)|Subutex®|Temgesic®
Buprenophine
Buprenorfina
Buprenorfina [INN-Spanish]
BUPRENORPHINE
Buprenorphine grünenthal brand
Buprenorphine Hcl
Buprenorphine hydrochloride
Buprenorphinum
Buprenorphinum [INN-Latin]
Buprex
|
BUTEC
BUTRANS
Essex brand OF buprenorphine hydrochloride
Grünenthal brand OF buprenorphine
Grünenthal brand OF buprenorphine hydrochloride
HAPOCTASIN
Hydrochloride, buprenorphine
Key brand OF buprenorphine hydrochloride
PANITAZ
Prefin
PRENOTRIX
Probuphine
Reckitt and colman brand 1 OF buprenorphine hydrochloride
Reckitt and colman brand 2 OF buprenorphine hydrochloride
Reckitt benckiser brand OF buprenorphine hydrochloride
Reckitt brand OF buprenorphine hydrochloride
RELETRANS
RX 6029 m
RX-6029-m
Schering plough brand OF buprenorphine hydrochloride
Schering-plough brand OF buprenorphine hydrochloride
SEVODYNE
SUBLOCADE
Subutex
Temgesic
Temgésic
TEPHINE
TRANSTEC
|
|
30 |
|
Mifepristone |
Approved, Investigational |
Phase 2, Phase 3 |
|
84371-65-3 |
55245 |
Synonyms:
11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one
Contragest brand OF mifepristone
Corlux
Danco brand OF mifepristone
Exelgyn brand OF mifepristone
Korlym
Mifegyne
Mifégyne
Mifeprex
Mifeprex®|RU-486|RU486
Mifepriston
|
Mifepristona
Mifepristone
Mifépristone
Mifepristone contragest brand
Mifepristone danco brand
Mifepristone exelgyn brand
Mifepristonum
RU-38486
RU486
RU-486
|
|
31 |
|
Naloxone |
Approved, Vet_approved |
Phase 2, Phase 3 |
|
465-65-6 |
5284596 |
Synonyms:
(-)-Naloxone
(−)-NALOXONE
(-)-naloxone|Kloxxado® (naloxone hydrochloride nasal spray)|l-naloxone|Narcan®|Nyxoid®
[<i>N</i>-allyl-2,3-<sup>3</sup>H]naloxone
17-Allyl-3,14-dihydroxy-4,5a-epoxymorphinan-6-one
17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one
17-Allyl-3,14-dihydroxy-4,5α-epoxymorphinan-6-one
1-N-Allyl-14-hydroxynordihydromorphinone
Abello brand OF naloxone hydrochloride
Abello, naloxone
Boots brand OF naloxone hydrochloride
Bristol myers squibb brand OF naloxone hydrochloride
Bristol-myers squibb brand OF naloxone hydrochloride
Curamed brand OF naloxone hydrochloride
Curamed, naloxon
DBL Naloxone
Dihydride, naloxone hydrochloride
EN 1530 base
endo Brand OF naloxone hydrochloride
Hydrobromide, naloxone
Hydrochloride dihydride, naloxone
Hydrochloride, naloxone
Lamepro brand OF naloxone hydrochloride
L-Naloxone
MRZ 2593 BR
MRZ 2593BR
MRZ 2593-BR
N-Allylnoroxymorphone
|
Nalone
Nalossone
Nalossone [Dcit]
Naloxon curamed
Naloxon ratiopharm
Naloxona
Naloxona [INN-Spanish]
NALOXONE
Naloxone abello
Naloxone HCl
Naloxone hydrobromide
Naloxone hydrochloride
Naloxone hydrochloride dihydride
Naloxone hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-isomer
Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-isomer
Naloxonratiopharm
Naloxon-ratiopharm
Naloxonum
Naloxonum [INN-Latin]
Narcan
Narcanti
Narcon
NSC-70413
Ratiopharm brand OF naloxone hydrochloride
SERB brand OF naloxone hydrochloride
SUBOXONE
United drug brand OF naloxone hydrochloride
|
|
32 |
|
Dexetimide |
Withdrawn |
Phase 2, Phase 3 |
|
21888-98-2 |
30843 |
Synonyms:
(+)-BENZETIMIDE
(+)-benzetimide|R 16470|Tremblex®
Dexetimida
DEXETIMIDE
|
Dexetimidum
R 16470
R-16470 [AS HYDROCHLORIDE]
TREMBLEX
|
|
33 |
|
1,2-Dihydroxybenzene |
Experimental |
Phase 2, Phase 3 |
|
120-80-9 |
289 |
Synonyms:
1,2-Benzenediol
1,2-Dihydroxybenzene
1,2-Hydroxybenzene
1,3-Dihydroxybenzene
2-Hydroxyphenol
a-Hydroxyphenol
alpha-Hydroxyphenol
Benzene-1,2-diol
Brenzcatechin
Catechol
Catechol dipotassium salt
Catechol sodium salt
Catechol, 14C-labeled CPD
Durafur developer C
Fouramine PCH
Fourrine 68
|
O-Benzenediol
O-Dihydroxybenzene
O-Dioxybenzene
O-Hydroquinone
O-Hydroxyphenol
O-Phenylenediol
Oxyphenate
Oxyphenic acid
Pelagol grey C
Phthalhydroquinone
Phthalic alcohol
Pyrocatechin
Pyrocatechine
Pyrocatechol
Α-hydroxyphenol
|
|
34 |
|
Adderall |
|
Phase 2, Phase 3 |
|
|
|
35 |
|
Serotonin Uptake Inhibitors |
|
Phase 2, Phase 3 |
|
|
|
36 |
|
Analgesics |
|
Phase 2, Phase 3 |
|
|
|
37 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 2, Phase 3 |
|
|
|
38 |
|
Parasympatholytics |
|
Phase 3 |
|
|
|
39 |
|
Antiparkinson Agents |
|
Phase 3 |
|
|
|
40 |
|
Muscarinic Antagonists |
|
Phase 3 |
|
|
|
41 |
|
Cholinergic Antagonists |
|
Phase 3 |
|
|
|
42 |
|
Narcotics |
|
Phase 2, Phase 3 |
|
|
|
43 |
|
Biperiden lactate |
|
Phase 3 |
|
|
|
Synonyms:
|
44 |
|
Hypoglycemic Agents |
|
Phase 2, Phase 3 |
|
|
|
45 |
|
Narcotic Antagonists |
|
Phase 2, Phase 3 |
|
|
|
46 |
|
Monoamine Oxidase Inhibitors |
|
Phase 3 |
|
|
|
47 |
|
Adjuvants, Immunologic |
|
Phase 2, Phase 3 |
|
|
|
48 |
|
Pharmaceutical Solutions |
|
Phase 2, Phase 3 |
|
|
|
49 |
|
Immunologic Factors |
|
Phase 2, Phase 3 |
|
|
|
50 |
|
Aromatic Amino Acid Decarboxylase Inhibitors |
|
Phase 2, Phase 3 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 227)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine Dependence |
Unknown status |
NCT00495183 |
Phase 4 |
caffeine;Biperiden;Placebo |
2 |
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence |
Completed |
NCT00015275 |
Phase 4 |
|
3 |
A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence |
Completed |
NCT00223210 |
Phase 4 |
Quetiapine;PLacebo |
4 |
Efficacy of Quetiapine in the Reduction of Cocaine Use and Cravings in Individuals With Cocaine Dependence |
Completed |
NCT00232336 |
Phase 4 |
quetiapine |
5 |
A Randomized, Double-blind, Placebo-controlled, Trial of Lamotrigine add-on Therapy in Outpatients With Bipolar Disorder, Depressed or Mixed Phase and Cocaine Dependence |
Completed |
NCT00280293 |
Phase 4 |
Lamotrigine;Placebo |
6 |
A 12-week, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial of Citicoline as an add-on Therapy Will be Conducted in 200 Outpatients With Bipolar I Disorder and Cocaine Dependence. |
Completed |
NCT00619723 |
Phase 4 |
Citicoline;Placebo |
7 |
Neuroplasticity Following Theta-Burst Stimulation in Cocaine Use Disorder |
Recruiting |
NCT02927236 |
Phase 4 |
|
8 |
Dopamine Beta-hydroxylase Inhibition Induced Blunting of Dopaminergic Response to Psychostimulant Administration. A PET Exploration of the Mechanism of Action of a New Therapeutic Strategy in Cocaine Addicts |
Withdrawn |
NCT02134002 |
Phase 4 |
Disulfiram;Placebo |
9 |
Medication Development for Cocaine Dependence |
Unknown status |
NCT00249691 |
Phase 3 |
Topiramate + Cognitive Behavioral Therapy;Placebo + Cognitive Behavioral Therapy |
10 |
Novel Pharmacotherapy for Dual Dependence |
Unknown status |
NCT00448825 |
Phase 3 |
Topiramate + Cognitive Behavioral Therapy;Placebo + Cognitive Behavioral Therapy |
11 |
Dopamine Transporter (DAT) in Pharmacological Treatments of Cocaine Dependence. CAIMAN (Cocaine Addiction Imaging Medications and Neurotransmitters) Study |
Completed |
NCT00701532 |
Phase 3 |
Modafinil and PET (brain imaging);placebo |
12 |
A Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) for the Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) and Cocaine Dependence |
Completed |
NCT00553319 |
Phase 2, Phase 3 |
Placebo;Adderall-XR |
13 |
Bupropion-Enhanced CM for Cocaine Dependence |
Completed |
NCT02111798 |
Phase 2, Phase 3 |
Placebo;Bupropion XL |
14 |
Naltrexone and Psychosocial Treatments for the Treatment of Cocaine Dependence Complicated by Alcohol Dependence |
Completed |
NCT00167232 |
Phase 3 |
Naltrexone |
15 |
Dose Response Trial of Pergolide for Cocaine Dependence |
Completed |
NCT00000248 |
Phase 3 |
Pergolide |
16 |
Adaptive Treatment for Alcohol and Cocaine Dependence |
Completed |
NCT01032135 |
Phase 2, Phase 3 |
medication management |
17 |
Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence |
Completed |
NCT00032929 |
Phase 3 |
Selegiline |
18 |
Naltrexone and Psychosocial Treatments for the Treatment of Cocaine Dependence Complicated by Alcohol Dependence |
Completed |
NCT00218660 |
Phase 3 |
Naltrexone;Placebo |
19 |
Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence |
Completed |
NCT01811940 |
Phase 2, Phase 3 |
Adderall-ER;Topiramate |
20 |
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study |
Completed |
NCT01281202 |
Phase 2, Phase 3 |
Vigabatrin;Matching Placebo |
21 |
Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence |
Completed |
NCT01468012 |
Phase 2, Phase 3 |
levodopa carbidopa and entacapone (LCE);Placebo |
22 |
Preventing Injection Initiation: The Change the Cycle Randomized Controlled Trial. |
Completed |
NCT02774954 |
Phase 3 |
|
23 |
Progesterone Treatment for Cocaine-dependent Women: A Pilot Study |
Completed |
NCT00632099 |
Phase 2, Phase 3 |
Oral micronized progesterone;Placebo |
24 |
Investigation of the Effect of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients |
Completed |
NCT02255357 |
Phase 2, Phase 3 |
Placebo;Intranasal Oxytocin |
25 |
Project 1: Clinical Neurobiology of Serotonin and Addiction |
Completed |
NCT00732901 |
Phase 2, Phase 3 |
Escitalopram;Placebo |
26 |
Treatment of Adult ADHD in Methadone Patients |
Completed |
NCT00061087 |
Phase 2, Phase 3 |
Methylphenidate;Bupropion |
27 |
A Double-blind, Placebo-controlled Trial of Citicoline add-on Therapy in Patients With a History of Mania or Hypomania and Cocaine Abuse/Dependence |
Completed |
NCT00223236 |
Phase 3 |
Citicoline;Placebo |
28 |
Investigation of the Effects of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients |
Completed |
NCT01134198 |
Phase 2, Phase 3 |
Mifepristone;placebo |
29 |
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes |
Completed |
NCT01077024 |
Phase 3 |
|
30 |
Cocaine/Crack Dependence: A Study of the Possible Reduction of Compulsion Under the Use of Biperiden |
Completed |
NCT01251393 |
Phase 3 |
Biperiden;Placebo |
31 |
Cocaine Use Reduction With Buprenorphine (CURB) |
Completed |
NCT01402492 |
Phase 2, Phase 3 |
Buprenorphine + Naltrexone;Placebo + Naltrexone |
32 |
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence |
Unknown status |
NCT00737256 |
Phase 2 |
Aripiprazole;Perphenazine |
33 |
Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence |
Unknown status |
NCT00123383 |
Phase 2 |
Modafinil |
34 |
Effect of Magnetic Stimulation Repetitive Transcranial on Impulsivity in Cocaine Dependence. |
Unknown status |
NCT01397266 |
Phase 2 |
|
35 |
Effect of Repetitive Transcranial Magnetic Stimulation on Symptoms of Attention Deficit Hyperactivity Disorder and Cognitive Function In Cocaine Addicts |
Unknown status |
NCT01593982 |
Phase 2 |
|
36 |
Treating Cocaine Abuse: A Behavioral Approach |
Unknown status |
NCT01822327 |
Phase 2 |
|
37 |
A Sequenced Behavioral and Medication Intervention for Cocaine Dependence |
Completed |
NCT01986075 |
Phase 1, Phase 2 |
Mixed-Amphetamine Salts- Extended Release (MAS-ER);Placebo |
38 |
Sertraline Augmented With GABA Agents for Cocaine Dependence |
Completed |
NCT00654953 |
Phase 2 |
sertraline;Placebo;gabapentin |
39 |
A Phase II, Double-Blind, Placebo-Controlled, Trial Of NS2359 For The Treatment of Cocaine Dependence |
Completed |
NCT02798627 |
Phase 2 |
NS2359;placebo |
40 |
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence |
Completed |
NCT01704196 |
Phase 2 |
Nepicastat;Placebo |
41 |
A Phase II, Randomized, Double-Blind Trial of Varenicline for the Treatment of Cocaine Dependence |
Completed |
NCT01680887 |
Phase 2 |
Varenicline;Placebo |
42 |
Experiment 1: Adenosine Receptor A2A Antagonists and Cocaine Dependence |
Completed |
NCT00733993 |
Phase 1, Phase 2 |
Caffeine 150 MG;Placebo;Amphetamine;Caffeine 300 MG |
43 |
A Phase II, Double-Blind, Placebo-controlled, Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence |
Completed |
NCT00385268 |
Phase 2 |
acamprosate;placebo |
44 |
Neural Substrates of Emotion: Impact of Cocaine Dependence |
Completed |
NCT02682784 |
Phase 2 |
Oxytocin;Placebo |
45 |
Brain Function and Structure in Cocaine Dependence |
Completed |
NCT02080832 |
Phase 2 |
Citalopram;Placebo |
46 |
Pharmacotherapy & CM for Opioid and Cocaine Dependence |
Completed |
NCT00838981 |
Phase 1, Phase 2 |
Modafinil;Sugar Pill;Methadone |
47 |
A Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) and Topiramate for the Treatment of Cocaine Dependence |
Completed |
NCT00421603 |
Phase 2 |
Adderall-XR and Topiramate;Placebo |
48 |
5-HT2AR: 5HT2CR Balance in Brain Connectivity in Cocaine Dependence |
Completed |
NCT03921151 |
Phase 1, Phase 2 |
Mirtazapine 15 MG Oral Tablet |
49 |
PPARγ Agonist Treatment for Cocaine Dependence |
Completed |
NCT02774343 |
Phase 1, Phase 2 |
Pioglitazone;Placebo |
50 |
Contingency Management Plus Levodopa/Carbidopa for Treatment of Cocaine Dependence |
Completed |
NCT00713583 |
Phase 2 |
levodopa;Placebo |
|